Abstract
Endomyocardial biopsy (bx) remains the preferred mode of cardiac allograft rejection surveillance. The frequency and morbidity of acute cellular rejection (ACR) has decreased with modern immunosuppression. We studied the yield of bx in the 1st year after heart transplantation (HT) to determine if traditional protocols are justified.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
